UK markets closed

Arrowhead Pharmaceuticals, Inc. (ARWR)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
22.33-0.28 (-1.24%)
At close: 04:00PM EDT
22.33 +0.00 (+0.00%)
After hours: 05:53PM EDT
Show:
Income statement
Cash flow
Annual

Balance sheet

All numbers in thousands
Breakdown
30/09/2023
30/09/2022
30/09/2021
30/09/2020
Assets
Current assets
Cash
Cash and cash equivalents
110,891
108,005
184,434
143,583
Other short-term investments
292,735
268,391
183,355
171,910
Total cash
403,626
376,396
367,789
315,493
Net receivables
0
1,410
10,255
846
Other current assets
7,082
20,204
2,191
1,782
Total current assets
419,521
405,299
384,597
322,372
Non-current assets
Property, plant and equipment
Gross property, plant and equipment
377,510
200,142
88,885
63,322
Accumulated depreciation
-41,951
-31,554
-22,864
-16,304
Net property, plant and equipment
335,559
168,588
66,021
47,018
Equity and other investments
0
105,872
245,595
137,487
Intangible assets
10,262
11,962
13,663
15,363
Other long-term assets
210
218
272
264
Total non-current assets
346,031
286,640
325,551
200,132
Total assets
765,552
691,939
710,148
522,504
Liabilities and stockholders' equity
Liabilities
Current liabilities
Accounts payable
35,866
2,868
9,457
6,829
Accrued liabilities
57,726
59,107
23,774
13,450
Deferred revenues
866
74,099
111,055
19,291
Other current liabilities
435
-
-
17
Total current liabilities
105,456
138,850
146,536
40,682
Non-current liabilities
Deferred revenues
0
55,950
131,495
0
Total non-current liabilities
372,934
134,750
154,790
20,043
Total liabilities
478,390
273,600
301,326
60,725
Stockholders' equity
Common stock
200
198
197
195
Retained earnings
-1,026,030
-820,755
-644,692
-503,844
Accumulated other comprehensive income
-3,222
-136
-69
18
Total stockholders' equity
271,343
398,520
408,822
461,779
Total liabilities and stockholders' equity
765,552
691,939
710,148
522,504